Skip to main content
Premium Trial:

Request an Annual Quote

Lars Boesgaard

Roka Biosciences has appointed Lars Boesgaard as vice president and chief financial officer. He succeeds Steven Sobieski, who will continue his association with the company as a senior advisor.

Boesgaard most recently served as vice president of finance. When he joined Roka in 2009, Boesgaard served as controller of finance. From 2007 to 2009, he served as vice president of finance at Insulet Corporation. Between 2004 and 2007, he served as senior director of financial services at Alexion Pharmaceuticals. Boesgaard has also served in various financial roles at the Nielsen Company and Novo Nordisk.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.